CIB2是一种新的内源抑制器
Yihui Wang1,2, Jizheng Wang2, Ling Shi3
1Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China (Y.W., J. Hong).
Circulation
|May 2, 2023
概括
和整合素结合家族成员2蛋白 (CIB2) 能够防止心房重塑和动. 失去CIB2会加重心房动,而过度表达会减轻心房动,这表明CIB2是潜在的治疗点.
科学领域:
- 心血管生物学
- 分子心脏病学
- 遗传学
背景情况:
- 心房动 (AF) 是一种与心力衰竭,中风和死亡相关的普遍疾病.
- 耳前组织重塑对于AF复发至关重要,但其机制尚未完全理解.
- 研究非特征性心房特异性基因对于了解心房病变至关重要.
研究的目的:
- 确定参与心房生理和心律失常的新型心房特异基因.
- 阐明CIB2 (和整合素结合家族成员2蛋白) 在心房重塑和AF中的作用.
主要方法:
- 通过RNA测序确定了心房特异性和血管素II反应基因.
- 产生心肌细胞特异性CIB2淘汰和过度表达的小鼠模型.
- 进行了体内和体外电生理学,组织学和生物化学分析.
主要成果:
- 在AF患者和模型中,CIB2被确定为心房丰富蛋白的下调.
- 在压力下的CIB2损失加剧了AF和心房纤维化.
- 通过抑制CIB1介导的氨酸激活,缓解了CIB2过度表达的AF和纤维化.
结论:
- CIB2是一种新型内源调节剂,可防止心房重塑和心房动脉.
- CIB2的保护作用表明它是AF治疗的潜在治疗点.
相关概念视频
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
13
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
13
01:28Mechanism of Cardiac Arrhythmias
979
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
979